What are the opening hours?

Monday 9am - 5:30pm Tuesday 9am - 5:30pm Wednesday 9am - 5:30pm Thursday 9am - 5:30pm Friday 9am - 5:30pm

Leukaemia UK

Home
United Kingdom
London
Leukaemia UK

We are Leukaemia UK. We believe research has the power to stop leukaemia devastating lives.

Leukaemia UK funds ground-breaking research to stop leukaemia devastating lives by accelerating progress in diagnosis, treatment and care.

17/06/2026

From significantly poor survival to a highly manageable condition, the story of chronic myeloid leukaemia (CML) remains one of haematology's greatest success stories. 🩸

Just 25 years ago, patients with CML faced limited treatment options.

Allogeneic stem cell transplantation was the only potentially curative therapy, but it carried significant risks and long-term complications. Before the era of Imatinib, 5-year survival rates were often below 50%.

The introduction of Imatinib - the first targeted tyrosine kinase inhibitor (TKI), a drug designed to block the abnormal BCR::ABL protein that drives CML - transformed outcomes for patients worldwide.

Today, 5-year survival approaches 90%, and many patients can expect near-normal life expectancy.

This breakthrough paved the way for multiple generations of TKIs, further improving efficacy, tolerability, and treatment options for people living with CML.

This May, the haematology community celebrated the remarkable "molecule" that changed the course of CML treatment forever. More than a scientific achievement, it is a discovery that has transformed and continues to transform the lives of countless patients and families around the world. 👏

16/06/2026

A day of learning all about the latest advancements in blood cancer. 🩸🧠

This weekend, we were in Stockholm for the European Haematology Association conference.

Take a trip with us as we explore the latest in blood cancer research, clinical innovation, and patient advocacy at one of the leading global haematology meetings. 🌎

Keep an eye out over the next week for more research updates and relevant leukaemia news from the conference.

15/06/2026

Introducing some of the game-changing immunotherapy treatments for leukaemia…

𝐃𝐨𝐧𝐨𝐫 𝐋𝐲𝐦𝐩𝐡𝐨𝐜𝐲𝐭𝐞 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 (𝐃𝐋𝐈):

🔸 What is it?
DLI uses white blood cells from a healthy matched donor, usually the same stem cell donor.

🔸 When is it used?
Typically, after leukaemia relapses and post-stem cell transplant.

🔸 How does it work?
The donor immune cells are infused into the patient to help the immune system recognise and destroy remaining leukaemia cells - known as the graft-versus-leukaemia effect.

🔸 How effective is it?
Research shows DLI can lead to complete remission in 70-80% of relapsed CML cases, compared to less than 40% for relapsed acute leukaemia’s.

𝐈𝐧𝐭𝐞𝐫𝐟𝐞𝐫𝐨𝐧:

🔸 What is it?
A synthetic version of naturally occurring immune system proteins.

🔸 When is it used?
Primarily for treating chronic myeloid leukaemia (CML).

🔸 How does it work?
It slows the growth and division of cancer cells.

🔸 How is it currently used?
Once a mainstay treatment for CML, it’s now less common due to advances in targeted therapies like tyrosine kinase inhibitors.

13/06/2026

Happy ‘rebirthday’ to Alice, who recently celebrated one year since her life-saving stem cell transplant!! 🎈🎉

Alice was diagnosed with acute myeloid leukaemia (AML) in May 2024, and received a transplant from her sister Kate’s donor cells in May 2025.

One year on, Alice is thankfully still in remission and recovering well.

She even ran the London Marathon for Leukaemia UK in April, alongside her husband and her sister, who ran for team Anthony Nolan. 👏

On World Blood Cancer Day (28th May), Alice and her family celebrated her ‘rebirthday’ with cake and balloons - a term often used by transplant patients to mark the anniversary of their new immune system.

Join us in wishing Alice a very happy one year rebirthday! 🧡

11/06/2026

Your MP is your voice in Parliament. Ask them to join us and end the delays in diagnosing leukaemia: https://action.leukaemiauk.org.uk/ask-your-mp-to-count-us-in.

Right now, 1 in 4 people with leukaemia experience avoidable delays in their diagnosis. Delays that cost lives. ‼️

Last week, we delivered your 10,000+ signatures to the Prime Minister at Number 10, calling for an end to these delays.

But we need your help to ensure the Government takes action.

On Wednesday 24th June, we’re bringing this issue directly to Parliament at a Parliamentary Reception.

By asking your MP to attend, you can help ensure that people affected by leukaemia are heard at the heart of Government.

📝 Write to your MP today and ask them to join us. Just a few minutes of your time to help change lives.

10/06/2026

💬 Share your views and help to strengthen and amplify the voices of people affected by rare and less common cancers*, including leukaemia.

Cancer52, an alliance of over 100 cancer charities including Leukaemia UK, has launched its latest patient survey - and we’d love you to take part!

By sharing your views, experiences and challenges throughout your cancer journey, you’ll be helping to shape future policy and influencing work by Cancer52.

This could mean improved diagnosis, access to treatments and quality of life for people with rare and less common cancers like leukaemia.

The survey is completely anonymous and will close on Friday 10th July.

Fill in the survey here 👉 https://www.surveymonkey.com/r/c52patientsurvey

*Rare and less common cancers refers to all cancers other than the four most common: breast, bowel, lung and prostate.

08/06/2026

Monoclonal antibodies (mAbs) have made a huge impact in personalised cancer treatments. Here's a quick rundown 👇

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐦𝐨𝐧𝐨𝐜𝐥𝐨𝐧𝐚𝐥 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐢𝐞𝐬?

🔸 Antibody basics: Antibodies are proteins made by white blood cells (B-cells), these recognise and bind to invaders (antigens) - either on abnormal cells or pathogens (e.g. bacteria).

🔸 Lab-made antibodies: Scientists create mAbs in the lab to target cancer cells specifically by recognising specific markers on the cancer cells.

𝐀 𝐛𝐫𝐢𝐞𝐟 𝐡𝐢𝐬𝐭𝐨𝐫𝐲:

▪️ 1980s: Research into antibodies for targeted treatments began.

▪️ 1997: FDA approved rituximab (Rituxan) — the first monoclonal antibody approved for cancer treatment, transforming care for some leukaemias and lymphomas.

▪️ Today: Monoclonal antibodies are widely used in blood cancer treatment, with many approved therapies and ongoing clinical trials continuing to improve outcomes for patients.

𝐇𝐨𝐰 𝐭𝐡𝐞𝐲 𝐰𝐨𝐫𝐤:

1️⃣ Hybridomas: B-cells are combined with tumour cells - these are immortal and replicate quickly - to create hybridomas that produce lots of antibodies.

2️⃣ Targeting cancer: These antibodies are designed to bind to cancer cells, often carrying drugs that kill the cancer while sparing healthy cells.

Monoclonal antibodies are a game-changer in the treatment options against cancer! Follow us for more insights into immunotherapies.

06/06/2026

The World Cup is nearly here - which means it’s time for a sweepstake! ⚽

Whether you’re part of a sports club, friendship group, choir or school community, why not add some extra excitement to the tournament while supporting life-saving leukaemia research?

It’s super easy to get involved:

🏆 Sign up - get your team together and let us know you’re running a sweepstake.

🏆 Put all the teams into an online randomiser. Each person gets a team at random.

🏆 Ask everyone to make a donation of £5 - then donate 50% of the funds to Leukaemia UK and award the other 50% to the winner!

If your sweepstake is already organised, we’d still love your support.

You can help by sharing our sweepstake with others in your community and spreading the word.

Got a question or want to let us know you’re taking part? Get in touch at [email protected].

04/06/2026

Fancy going on an adventure of a lifetime, led by the iconic Jason Fox from SAS: Who Dares Wins? Yes, really!

We’re delighted to be one of four chosen cancer charities for next year’s Ultra 4 Charity events!

First up: Lapland in Northern Sweden.

Think frozen lakes, Arctic wildlife and the Northern Lights - every step will basically look like a Christmas card! ❄️

You can choose to run or walk one of three distances: 100km over two days, or 50km or 25km in a single day. With relaxed checkpoint cut‑offs, every distance is achievable for both runners and walkers.

And the best part? All of the money raised will be split between the four chosen charities. 🧡

These places WILL go fast! There are only 250 spots available across all distances, so get in quick.

Find out more and secure your spot: https://www.race-space.com/gb/ultra-4-charity/ultra-4-cancer-lapland-2027

02/06/2026

Over 10,000 of you signed our campaign calling to end the delays in leukaemia diagnosis. Today, we delivered your signatures to the Prime Minister at Number 10. ✅

1 in 4 people with leukaemia experience avoidable delays in their diagnosis. Delays that cost lives.

We campaigned for years to ensure that leukaemia was recognised in the National Cancer Plan.

Over the last few months, we've been calling on the Government to act and deliver its commitment to drive earlier diagnosis.

This means:

🔸 Faster referrals for full blood counts

🔸 Fewer people diagnosed in emergency settings

🔸 Access to specialist haematology care at the right time

Today, families, supporters and those affected by leukaemia brought their voices to Downing Street, as we delivered our campaign to those with the power to drive change.

Thank you so much to the thousands of you who have added your name and supported our call to end the delays.

We are here to support the Government in delivering this commitment - to drive earlier diagnosis, improve outcomes and ultimately save lives.

Let’s make this moment count. ✨

Address

26 Great Queen Street
London
WC2B5BL

Opening Hours

Monday	9am - 5:30pm
Tuesday	9am - 5:30pm
Wednesday	9am - 5:30pm
Thursday	9am - 5:30pm
Friday	9am - 5:30pm

Telephone

+442072990722

Website

http://www.leukaemiauk.org.uk/

Alerts

Be the first to know and let us send you an email when Leukaemia UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to Leukaemia UK:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Organisation
Claim ownership or report listing

Featured

British DJ & MC Academy
The grangeway
Hephzibar Foundation